{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:20:49Z","timestamp":1790011249786,"version":"4.0.1"},"reference-count":91,"publisher":"Impact Journals, LLC","issue":"25","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,4,3]]},"DOI":"10.18632\/oncotarget.24844","type":"journal-article","created":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T10:21:41Z","timestamp":1522664501000},"page":"17689-17710","source":"Crossref","is-referenced-by-count":69,"title":["The role of oxidative stress in activity of anticancer thiosemicarbazones"],"prefix":"10.18632","volume":"9","author":[{"given":"Katarzyna","family":"Malarz","sequence":"first","affiliation":[{"name":"Institute of Chemistry, University of Silesia in Katowice, Katowice, Poland"},{"name":"Silesian Center for Education and Interdisciplinary Research, University of Silesia in Katowice, Chorz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mrozek-Wilczkiewicz","sequence":"additional","affiliation":[{"name":"Silesian Center for Education and Interdisciplinary Research, University of Silesia in Katowice, Chorz\u00f3w, Poland"},{"name":"A. Che\u0142kowski Institute of Physics, University of Silesia in Katowice, Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Serda","sequence":"additional","affiliation":[{"name":"Institute of Chemistry, University of Silesia in Katowice, Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rejmund","sequence":"additional","affiliation":[{"name":"Institute of Chemistry, University of Silesia in Katowice, Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw","family":"Polanski","sequence":"additional","affiliation":[{"name":"Institute of Chemistry, University of Silesia in Katowice, Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Musiol","sequence":"additional","affiliation":[{"name":"Institute of Chemistry, University of Silesia in Katowice, Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2018,4,3]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrd4002","article-title":"Modulation of oxidative stress as an anticancer strategy","volume":"12","author":"Mak","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"2","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1158\/1078-0432.CCR-12-1424","article-title":"Molecular Pathways: Reactive Oxygen Species Homeostasis in Cancer Cells and Implications for Cancer Therapy","volume":"19","author":"Hay","year":"2013","journal-title":"Clin Cancer Res"},{"key":"3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s11888-013-0190-5","article-title":"Reactive oxygen species and colorectal cancer","volume":"9","author":"Safe","year":"2013","journal-title":"Curr Colorectal Cancer Rep"},{"key":"4","doi-asserted-by":"crossref","first-page":"1616781","DOI":"10.1155\/2016\/1616781","article-title":"Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer","volume":"2016","author":"Ma","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"5","first-page":"286","article-title":"Is redox signaling a feasible target for overcoming multidrug resistance in cancer chemotherapy?","volume":"5","author":"Gazzano","year":"2014","journal-title":"Front Pharmacol"},{"key":"6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Huang","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2174\/187231309787158271","article-title":"Reactive Oxygen Species, Cancer and Anti-Cancer Therapies","volume":"3","author":"Neagu","year":"2009","journal-title":"Curr Chem Biol"},{"key":"8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bcp.2014.07.017","article-title":"Targeting antioxidants for cancer therapy","volume":"92","author":"Chandel","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"9","first-page":"196","article-title":"Glutathione: new roles in redox signaling for an old antioxidant","volume":"5","author":"Ciriolo","year":"2014","journal-title":"Front Pharmacol"},{"key":"10","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.freeradbiomed.2009.12.022","article-title":"Reactive oxygen species, cellular redox systems, and apoptosis","volume":"48","author":"Aw","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"11","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1089\/ars.2012.4553","article-title":"Glutathione efflux and cell death","volume":"17","author":"Cidlowski","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"12","first-page":"972913","article-title":"Role of glutathione in cancer progression and chemoresistance","volume":"2013","author":"Domenicotti","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00280-003-0726-5","article-title":"Intrinsic oxidative stress in cancer cells: A biochemical basis for therapeutic selectivity","volume":"53","author":"Huang","year":"2004","journal-title":"Cancer Chemother Pharmacol"},{"key":"14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bbamcr.2016.01.026","article-title":"Redox cycling metals: pedaling their roles in metabolism and their use in the development of n ovel therapeutics","volume":"1863","author":"Merlot","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/pr.57.4.2","article-title":"The evolution of iron chelators for the treatment of iron overload disease and cancer","volume":"57","author":"Richardson","year":"2005","journal-title":"Pharmacol Rev"},{"key":"16","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1039\/C5MT00149H","article-title":"Targeting copper in cancer therapy: \u201cCopper That Cancer\u201d","volume":"7","author":"Cater","year":"2015","journal-title":"Metallomics"},{"key":"17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/10715761003667554","article-title":"Reactive oxygen species in cancer","volume":"44","author":"Storz","year":"2010","journal-title":"Free Radic Res"},{"key":"18","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/jcph.113","article-title":"Iron Chelation in the Treatment of Cancer: A New Role for Deferasirox?","volume":"53","author":"Tselepis","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"19","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.2174\/092986712800609706","article-title":"Iron chelators for the treatment of cancer","volume":"19","author":"Richardson","year":"2012","journal-title":"Curr Med Chem"},{"key":"20","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1021\/jm070445z","article-title":"Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents","volume":"50","author":"Richardson","year":"2007","journal-title":"J Med Chem"},{"key":"21","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1021\/jm100561b","article-title":"Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor activity","volume":"53","author":"Richardson","year":"2010","journal-title":"J Med Chem"},{"key":"22","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1182\/blood-2004-05-1866","article-title":"Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: A link between iron metabolism and proliferation","volume":"104","author":"Richardson","year":"2004","journal-title":"Blood"},{"key":"23","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1021\/jm0606342","article-title":"Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity","volume":"49","author":"Bernhardt","year":"2006","journal-title":"J Med Chem"},{"key":"24","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.bbamcr.2016.04.017","article-title":"Lysosomal membrane stability plays a major role in the cytotoxic activity of the anti-proliferative agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT)","volume":"1863","author":"Richardson","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"25","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1089\/ars.2012.4540","article-title":"Novel chelators for cancer treatment: where are we now?","volume":"18","author":"Richardson","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"26","doi-asserted-by":"crossref","first-page":"9588","DOI":"10.1074\/jbc.M114.631283","article-title":"Di-2-pyridylketone 4,4-Dimethyl-3-thiosemicarbazone (Dp44mT) Overcomes Multidrug-Resistance by a Novel Mechanism Involving the Hijacking of Lysosomal P-Glycoprotein (Pgp)","volume":"290","author":"Richardson","year":"2015","journal-title":"J Biol Chem"},{"key":"27","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1021\/jm200924c","article-title":"Halogenated 2\u2032-benzoylpyridine thiosemicarbazone (XBpT) chelators with potent and selective anti-neoplastic activity: relationship to intracellular redox activity","volume":"54","author":"Richardson","year":"2011","journal-title":"J Med Chem"},{"key":"28","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.bbagen.2008.04.003","article-title":"Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents","volume":"1790","author":"Lovejoy","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"29","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1124\/mol.111.073627","article-title":"Novel thiosemicarbazone iron chelators induce up-regulation and phosphorylation of the metastasis suppressor N-myc down-stream regulated gene 1: a new strategy for the treatment of pancreatic cancer","volume":"80","author":"Richardson","year":"2011","journal-title":"Mol Pharmacol"},{"key":"30","doi-asserted-by":"crossref","first-page":"e87268","DOI":"10.1371\/journal.pone.0087268","article-title":"Global gene expression analysis reveals a link between NDRG1 and vesicle transport","volume":"9","author":"Frengen","year":"2014","journal-title":"PLoS One"},{"key":"31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10637-007-9066-3","article-title":"A Phase II study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and gemcitabine in advanced pancreatic carcinoma. A trial of the Princess Margaret hospital Phase II consortium","volume":"25","author":"Moore","year":"2007","journal-title":"Invest New Drugs"},{"key":"32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.phrs.2015.08.013","article-title":"The renaissance of polypharmacology in the development of anti-cancer therapeutics: Inhibition of the \u201c Triad of Death \u201d in cancer by Di-2-pyridylketone thiosemicarbazones","volume":"100","author":"Richardson","year":"2015","journal-title":"Pharmacol Res"},{"key":"33","doi-asserted-by":"crossref","first-page":"14901","DOI":"10.1073\/pnas.0604979103","article-title":"A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics","volume":"103","author":"Richardson","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"34","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1016\/j.bmcl.2012.07.030","article-title":"Synthesis and characterization of quinoline-based thiosemicarbazones and correlation of cellular iron-binding efficacy to anti-tumor efficacy","volume":"22","author":"Polanski","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"35","doi-asserted-by":"crossref","first-page":"e110291","DOI":"10.1371\/journal.pone.0110291","article-title":"Exploring the anti-cancer activity of novel thiosemicarbazones generated through the combination of retro-fragments: dissection of critical structure-activity relationships","volume":"9","author":"Polanski","year":"2014","journal-title":"PLoS One"},{"key":"36","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1021\/ml400422a","article-title":"Iron Chelators in Photodynamic Therapy Revisited: Synergistic Effect by Novel Highly Active Thiosemicarbazones","volume":"5","author":"Polanski","year":"2014","journal-title":"ACS Med Chem Lett"},{"key":"37","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.7150\/jca.17959","article-title":"Iron Chelators and Exogenic Photosensitizers. Synergy through Oxidative Stress Gene Expression","volume":"8","author":"Musiol","year":"2017","journal-title":"J Cancer"},{"key":"38","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1016\/j.bmc.2015.05.006","article-title":"Selective induction of oxidative stress in cancer cells via synergistic combinations of agents targeting redox homeostasis","volume":"23","author":"Parkinson","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"39","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1182\/blood.V98.3.842","article-title":"The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents, IV: The mechanisms involved in inhibiting cell-cycle progression","volume":"98","author":"Richardson","year":"2001","journal-title":"Blood"},{"key":"40","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1158\/0008-5472.CAN-11-1218","article-title":"Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes","volume":"71","author":"Richardson","year":"2011","journal-title":"Cancer Res"},{"key":"41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10534-015-9905-1","article-title":"Improved cytotoxicity of pyridyl-substituted thiosemicarbazones against MCF-7 when used as metal ionophores","volume":"29","author":"Parkinson","year":"2016","journal-title":"Biometals"},{"key":"42","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s10534-016-9945-1","article-title":"Investigation of the cytotoxic implications of metal chelators against melanoma and approaches to improve the cytotoxicity profiles of metal coordinating agents","volume":"29","author":"Parkinson","year":"2016","journal-title":"Biometals"},{"key":"43","doi-asserted-by":"publisher","first-page":"5032","DOI":"10.1021\/jm900528d","article-title":"Impact of metal coordination on cytotoxicity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and novel insights into terminal dimethylation","volume":"52","author":"Keppler","year":"2009","journal-title":"J Med Chem"},{"key":"44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.phrs.2016.12.001","article-title":"Metals and metastasis: Exploiting the role of metals in cancer metastasis to develop novel anti-metastatic agents","volume":"115","author":"Kovacevic","year":"2017","journal-title":"Pharmacol Res"},{"key":"45","doi-asserted-by":"crossref","first-page":"e0149922","DOI":"10.1371\/journal.pone.0149922","article-title":"Correction: n-myc Downstream Regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion","volume":"11","author":"Richardson","year":"2016","journal-title":"PLoS One"},{"key":"46","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1021\/ja00319a043","article-title":"Tris(phenanthroline)ruthenium(11): Stereoselectivity in Binding to DNA","volume":"106","author":"Goldberg","year":"1984","journal-title":"J Am Chem Soc"},{"key":"47","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1021\/bi401687v","article-title":"Interaction of Doxorubicin with Polynucleotides. A Spectroscopic Study","volume":"53","author":"Giustini","year":"2014","journal-title":"Biochemistry"},{"key":"48","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/ijms17071042","article-title":"Analysis of the Interaction of Dp44mT with Human Serum Albumin and Calf Thymus DNA Using Molecular Docking and Spectroscopic Techniques","volume":"17","author":"Li","year":"2016","journal-title":"Int J Mol Sci"},{"key":"49","doi-asserted-by":"crossref","first-page":"e0142678","DOI":"10.1371\/journal.pone.0142678","article-title":"Design, synthesis andactivity of anticancer styrylquinolines. The p53 independent mechanism of action","volume":"10","author":"Musiol","year":"2015","journal-title":"PLoS One"},{"key":"50","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/iub.253","article-title":"Metal ionophores - An emerging class of anticancer drugs","volume":"61","author":"Lind","year":"2009","journal-title":"IUBMB Life"},{"key":"51","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2174\/1574892811308020005","article-title":"Aryl- and heteroaryl-thiosemicarbazone derivatives and their metal complexes: a pharmacological template","volume":"8","author":"Fernandes","year":"2013","journal-title":"Recent Patents Anticancer Drug Discov"},{"key":"52","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1021\/jm000979z","article-title":"Synthesis, cytotoxicity, and antitumor activity of copper(II) and iron(II) complexes of 4N-azabicyclo[3.2.2]nonane Thiosemicarbazones derived from acyl diazines","volume":"44","author":"Hofmann","year":"2001","journal-title":"J Med Chem"},{"key":"53","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1158\/1535-7163.MCT-05-0384","article-title":"A ferrous-Triapine complex mediates formation of reactive oxygen species chat inactivate human ribonucleotide reductase","volume":"5","author":"Yen","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"54","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0304-3835(01)00421-9","article-title":"Different kinds of reactive oxygen and nitrogen species were detected in colon and breast tumors","volume":"165","author":"Yal\u00e7in","year":"2001","journal-title":"Cancer Lett"},{"key":"55","first-page":"2685","article-title":"Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma","volume":"22","author":"Head","year":"2002","journal-title":"Anticancer Res"},{"key":"56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.taap.2016.02.024","article-title":"Iron depletion in HCT116 cells diminishes the upregulatory effect of phenethyl isothiocyanate on heme oxygenase-1","volume":"297","author":"Loo","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"57","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3495","article-title":"Iron and cancer: more ore to be mined","volume":"13","author":"Torti","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"58","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3892\/ijo.2013.2063","article-title":"Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin","volume":"43","author":"Pogribny","year":"2013","journal-title":"Int J Oncol"},{"key":"59","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s10637-010-9481-8","article-title":"The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells","volume":"29","author":"Meng","year":"2011","journal-title":"Invest New Drugs"},{"key":"60","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0006-2952(99)00419-0","article-title":"Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity","volume":"59","author":"Sartorelli","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"61","first-page":"402","article-title":"Examination of the antiproliferative activity of iron chelators: Multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311","volume":"9","author":"Richardson","year":"2003","journal-title":"Clin Cancer Res"},{"key":"62","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ctrv.2008.07.004","article-title":"Elevated copper and oxidative stress in cancer cells as a target for cancer treatment","volume":"35","author":"Mumper","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"63","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.cdd.4400959","article-title":"Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line","volume":"9","author":"Knox","year":"2002","journal-title":"Cell Death Differ"},{"key":"64","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1158\/0008-5472.CAN-2287-2","article-title":"p53-Induced Up-Regulation of MnSOD and GPx but not Catalase Increases Oxidative Stress and Apoptosis","volume":"64","author":"Nagashima","year":"2004","journal-title":"Cancer Res"},{"key":"65","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.cbi.2011.06.009","article-title":"Involvement of catalase in the apoptotic mechanism induced by apigenin in HepG2 human hepatoma cells","volume":"193","author":"Rocha","year":"2011","journal-title":"Chem Biol Interact"},{"key":"66","doi-asserted-by":"crossref","first-page":"e35584","DOI":"10.1371\/journal.pone.0035584","article-title":"Factors determining sensitivity and resistance of tumor cells to arsenic trioxide","volume":"7","author":"Efferth","year":"2012","journal-title":"PLoS One"},{"key":"67","first-page":"4541","article-title":"Catalase protects tumor cells from apoptosis induction by intercellular ROS signaling","volume":"29","author":"Bauer","year":"2009","journal-title":"Anticancer Res"},{"key":"68","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1093\/carcin\/bgl146","article-title":"The metastasis suppressor, Ndrg-1: A new ally in the fight against cancer","volume":"27","author":"Richardson","year":"2006","journal-title":"Carcinogenesis"},{"key":"69","doi-asserted-by":"crossref","first-page":"29386","DOI":"10.1074\/jbc.270.49.29386","article-title":"A p53-independent pathway for activation of WAF1\/CIP1 expression following oxidative stress","volume":"270","author":"Appella","year":"1995","journal-title":"J Biol Chem"},{"key":"70","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.cdd.4401322","article-title":"p53-independent induction of p21(waf1\/cip1) contributes to the activation of caspases in GTP-depletion-induced apoptosis of insulin-secreting cells","volume":"11","author":"Li","year":"2004","journal-title":"Cell Death Differ"},{"key":"71","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/carcin\/bgr046","article-title":"The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms","volume":"32","author":"Richardson","year":"2011","journal-title":"Carcinogenesis"},{"key":"72","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1089\/ars.2013.5303","article-title":"Manganese superoxide dismutase regulates a redox cycle within the cell cycle","volume":"20","author":"Goswami","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"73","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1089\/ars.2009.2513","article-title":"Redox control of the cell cycle in health and disease","volume":"11","author":"Goswami","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"74","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1158\/0008-5472.CAN-11-1063","article-title":"Manganese Superoxide Dismutase Regulates a Metabolic Switch during the Mammalian Cell Cycle","volume":"72","author":"Goswami","year":"2012","journal-title":"Cancer Res"},{"key":"75","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/jmcb\/mjs062","article-title":"CyclinB1\/Cdk1 phosphorylates mitochondrial antioxidant MnSOD in cell adaptive response to radiation stress","volume":"5","author":"Li","year":"2013","journal-title":"J Mol Cell Biol"},{"key":"76","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nature02062","article-title":"Targets of the cyclin-dependent kinase Cdk1","volume":"425","author":"Morgan","year":"2003","journal-title":"Nature"},{"key":"77","doi-asserted-by":"crossref","first-page":"e0136878","DOI":"10.1371\/journal.pone.0136878","article-title":"G2\/M Cell Cycle Arrest and Tumor Selective Apoptosis of Acute Leukemia Cells by a Promising Benzophenone Thiosemicarbazone Compound","volume":"10","author":"Davio","year":"2015","journal-title":"PLoS One"},{"key":"78","doi-asserted-by":"crossref","first-page":"e24312","DOI":"10.1371\/journal.pone.0024312","article-title":"Role of cyclin B1\/Cdc2 up-regulation in the development of mitotic prometaphase arrest in human breast cancer cells treated with nocodazole","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"key":"79","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ceb.2013.07.003","article-title":"Mitosis and apoptosis: how is the balance set?","volume":"25","author":"Taylor","year":"2013","journal-title":"Curr Opin Cell Biol"},{"key":"80","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1039\/C4DT03764B","article-title":"Synthesis, X-ray structure andcytotoxicity studies of Cu(I\/II) complexes of thiosemicarbazone: special emphasis on their interactions with DNA","volume":"44","author":"Dinda","year":"2015","journal-title":"Dalton Trans"},{"key":"81","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2147\/DDDT.S49763","article-title":"8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications","volume":"7","author":"Prachayasittikul","year":"2013","journal-title":"Drug Des Devel Ther"},{"key":"82","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1039\/C5NJ00594A","article-title":"Iron(III) and nickel(ii) complexes as potential anticancer agents: Synthesis, physicochemical and structural properties, cytotoxic activity and DNA interactions","volume":"39","author":"\u00dclk\u00fcseven","year":"2015","journal-title":"New J Chem"},{"key":"83","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1021\/acs.chemrestox.5b00471","article-title":"Examination of the Impact of Copper(II) \u03b1-(N )-Heterocyclic Thiosemicarbazone Complexes on DNA Topoisomerase II\u03b1","volume":"29","author":"Deweese","year":"2016","journal-title":"Chem Res Toxicol"},{"key":"84","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejmech.2016.01.061","article-title":"Small molecule glycoconjugates with anticancer activity","volume":"112","author":"Musiol","year":"2016","journal-title":"Eur J Med Chem"},{"key":"85","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1089\/ars.2012.4877","article-title":"Iron chelators with topoisomerase-inhibitory activity and their anticancer applications","volume":"18","author":"Rao","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"86","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.copbio.2007.09.006","article-title":"DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action","volume":"18","author":"Hergenrother","year":"2007","journal-title":"Curr Opin Biotechnol"},{"key":"87","doi-asserted-by":"crossref","first-page":"11947","DOI":"10.1021\/ja991844p","article-title":"DNA Binding Mode and Sequence Specificity of Piperazinylcarbonyloxyethyl Derivatives of Anthracene and Pyrene","volume":"121","author":"Nord\u00e9n","year":"1999","journal-title":"J Am Chem Soc"},{"key":"88","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1158\/0008-5472.CAN-08-1437","article-title":"The iron chelator Dp44mT causes DNA damage and selective inhibition of topoisomerase IIA in breast cancer cells","volume":"69","author":"Shacter","year":"2009","journal-title":"Cancer Res"},{"key":"89","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bcp.2012.03.021","article-title":"The anticancer thiosemicarbazones Dp44mT and triapine lack inhibitory effects as catalytic inhibitors or poisons of DNA topoisomerase II\u03b1","volume":"84","author":"Hasinoff","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"90","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00001813-199304000-00017","article-title":"The cytotoxicity of copper(II) complexes of heterocyclic thiosemicarbazones and 2-substituted pyridine N-oxides","volume":"4","author":"Hall","year":"1993","journal-title":"Anticancer Drugs"},{"key":"91","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1038\/nprot.2006.378","article-title":"Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method","volume":"1","author":"Biswas","year":"2006","journal-title":"Nat Protoc"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:00:12Z","timestamp":1751536812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,3]]},"references-count":91,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2018,4,3]]}},"alternative-id":["24844","29707141"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.24844","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,3]]}}}